Physician profile
Mark Pelka
NPI 1114389418
$8,833.80
in general payments reported to CMS, 2019-2025
24 companies · $847 in 2025
The $847 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2021: $34.32 · 2022: $507 · 2023: $4,828 · 2024: $2,511 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Food and Beverage: $3,119 · Travel and Lodging: $969 · Education: $98.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Food and Beverage | $3,119.20 |
| Travel and Lodging | $968.53 |
| Education | $98.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,148.24 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Edwards Lifesciences Corporation | $956.44 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Abiomed | $375.42 | 2022-2025 | Impella |
| Abbott Laboratories | $330.45 | 2021-2025 | Mitraclip, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit |
| Inari Medical, INC. | $129.01 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $111.17 | 2023 | Gore Cardioform Septal Occluder, Gore Viabahn Vbx Balloon Expandable Endo |
| Janssen Pharmaceuticals, INC | $106.85 | 2019 | |
| Cardiovascular Systems INC. | $90.58 | 2023 | Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.58 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $66.97 | 2021-2025 | |
| Terumo Medical Corporation | $61.04 | 2023 | Metacross Otw, Glidewire, Glidesheath Slender |
| Biosense Webster, INC. | $47.27 | 2023-2024 | Na |
| Actelion Pharmaceuticals US, INC. | $42.02 | 2024 | Uptravi |
| Cardiva Medical, INC. | $40.19 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Surmodics, INC. | $38.27 | 2022-2024 | Pounce Thrombectomy, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sundance Drug Coated Balloon |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $37.99 | 2025 | |
| Penumbra, INC. | $31.86 | 2022 | |
| Pfizer INC. | $27.46 | 2025 | |
| Getinge USA Sales, LLC | $26.53 | 2023 | Cardiosave Hybrid, Type B Plug |
| Shockwave Medical, INC | $21.58 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $19.30 | 2024 | Verquvo |
| Livanova USA, INC. | $13.92 | 2022 | |
| Amgen INC. | $13.52 | 2025 | Repatha |
| Biotronik INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pelka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.